
|Articles|September 29, 2000
FDA Approves RU-486
Advertisement
WASHINGTON - The Food and Drug Administration (FDA) approved the abortion pill RU-486. Within a month, doctors will be able to prescribe the drug Mifeprex, or mifepristone, for women who are as much as seven weeks pregnant.
Despite warnings that the FDA would impose limitations on doctors who offer the pill, yesterdays approval came with relatively minor restrictions. The rules given require that doctors who prescribe Mifeprex be able to determine how far along a pregnancy is and must either be able to perform surgical abortions or have a pre-existing agreement with another physician who is qualified to conduct such surgery. For more information visit www.fda.gov.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Infection Control Today
1
Roche Expands Cyclospora PCR Testing Portfolio to Support Ongoing US Outbreak Response
2
Burnout to Balance: How Mentorship Helped One Infection Preventionist Reclaim Her Purpose
3
Can We Prepare for the Next Pandemic Without Studying Dangerous Pathogens? Experts Question New Gain-of-Function Policy
4
Lead Apron Safety Requires Collaboration Across Infection Prevention, OR, and Radiology Teams
5






